In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recent transactionsRecursion Pharmaceuticals insiders reported 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax payment, with the remaining 2 transactions valued at $0.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results